Previous 10 | Next 10 |
Dynavax to Report Second Quarter 2023 Financial Results and Host Conference Call on August 3, 2023 PR Newswire EMERYVILLE, Calif. , July 20, 2023 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company dev...
2023-07-19 11:00:00 ET Summary Pharmaceuticals/biotechnology is the most attractive subsector regarding both value and quality scores. Healthcare equipment is the most overpriced healthcare industry. Fast facts on iShares U.S. Healthcare ETF. 10 healthcare stocks cheaper t...
2023-06-19 05:16:46 ET Summary Pharma/biotechnology and healthcare providers are slightly undervalued relative to 11-year averages. Healthcare equipment is the most overvalued subsector. Fast facts on PBE, a genomics ETF. 10 healthcare stocks cheaper than their peers in Ju...
Dynavax to Present at Upcoming Investor Conferences PR Newswire EMERYVILLE, Calif. , May 30, 2023 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vacc...
2023-05-24 13:33:04 ET In its preliminary annual 2023 Russell indexes reconstitution, a total of 164 companies will be added and 319 deleted from the Russell microcap index. Following notable healthcare companies will be added and deleted from Russell microcap index: Notable additio...
Dynavax to Present at the JMP Securities Life Sciences Conference PR Newswire EMERYVILLE, Calif. , May 8, 2023 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing in...
2023-05-03 15:17:55 ET Summary Today, we put Dynavax Technologies Corporation in the spotlight, as the vaccine concern reported first quarter earnings after the bell on Tuesday. While the company's Covid-related revenues have largely ended, its HEPLISAV-B franchise continues to ta...
2023-05-02 22:00:18 ET Image source: The Motley Fool. Dynavax Technologies (NASDAQ: DVAX) Q1 2023 Earnings Call May 02, 2023 , 4:30 p.m. ET Operator Continue reading For further details see: Dynavax Technologies (DVAX) Q1 2023 Earnings Ca...
2023-05-02 19:33:06 ET Dynavax Technologies Corporation (DVAX) Q1 2023 Earnings Conference Call May 2, 2023, 04:30 PM ET Company Participants Paul Cox - VP of IR and Corporate Communications Ryan Spencer - CEO Donn Casale - Chief Commercial Officer Rob Jansse...
2023-05-02 17:11:45 ET Although its Q1 2023 bottom line results came in below expectations, Dynavax Technologies ( NASDAQ: DVAX ) is trading flat in after-hours trading. The boost could be the result of a sigh of relief from investors as the company maintained its 2023 financi...
News, Short Squeeze, Breakout and More Instantly...
Dynavax Technologies Corporation Company Name:
DVAX Stock Symbol:
NASDAQ Market:
Dynavax Technologies Corporation Website:
Dynavax to Report Second Quarter 2024 Financial Results and Host Conference Call on August 6, 2024 PR Newswire EMERYVILLE, Calif. , July 23, 2024 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company dev...
Dynavax Initiates Phase 1/2 Study of Novel Shingles Vaccine Program PR Newswire EMERYVILLE, Calif. , June 27, 2024 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing inn...
2024-06-21 02:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...